Cdc7-IN-7
Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].
Product Specifications
CAS Number
[1402059-17-9]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C(C(C/1=O)=C(NN2CCOCC2)OC1=C/C3=CNC4=NC=CC=C43)OCC5CC5
Molecular Formula
C21H22N4O5
Molecular Weight
410.42
References & Citations
[1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1105346-01 0.05 mg (E-Coli)
Recombinant Janthinobacterium sp. Urease accessory protein UreE (ureE)
Ask
View Details 
MBS1105346-02 0.05 mg (Yeast)
Recombinant Janthinobacterium sp. Urease accessory protein UreE (ureE)
Ask
View Details 
MBS1105346-03 0.2 mg (E-Coli)
Recombinant Janthinobacterium sp. Urease accessory protein UreE (ureE)
Ask
View Details MBS1105346-04 0.5 mg (E-Coli)
Recombinant Janthinobacterium sp. Urease accessory protein UreE (ureE)
Ask
View Details MBS1105346-05 0.05 mg (Baculovirus)
Recombinant Janthinobacterium sp. Urease accessory protein UreE (ureE)
Ask
View Details